Jeffrey Finney

Health Science at Towson University | Accredited Investor & Derivatives Trader

📍 United States🔄 Updated September 2026💼 4 investments📅 1 years investing🗓 Last invested May 2026
Angel investor🌍 United StatesInvested this year
4
Total investments
0
Early stage
0
Mid stage
1
Late stage
1y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
May 2025
Hims & Hers Health, Inc. (better known as Hims & Hers) is a multi-specialty telehealth platform building a virtual front door to the healthcare system. We connect consumers to licensed healthcare professionals, enabling people to access high-quality medical care—from wherever is most convenient—for numerous conditions related to sexual health, hair care, mental health, skincare, primary care, and more. With products and services available across all 50 states and Washington, D.C., Hims & Hers is on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. We normalize health & wellness challenges—and innovate on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so we provide access to personalized care designed for results. At our core, our mission is deeply personal—because we too are customers. In January 2021, the company was listed on the NYSE and is traded under the ticker symbol “HIMS”. To learn more about our brand and offerings, you can visit hims.com and forhers.com.
Experience · 4 entries
All (4)
Investments (4)
2026
Investor
May 2026
Duolingo is the most downloaded education app in the history of the App Store. Our mission is to develop the best education in the world and make it universally available. Learning a new language is hard, but staying motivated is often the hardest part. That’s why we use fun, bite-sized, game-like lessons designed to keep you engaged and to drive real learning outcomes. Our approach is grounded in efficacy: we continuously test and improve our methods to ensure learners make meaningful progress. We also believe in democratizing education by offering an effective, high-quality free product. Developing a great free product is essential to our mission, ensuring that anyone with a smartphone can access learning that works. When it comes to utilizing AI tools, we have a golden rule: we use it when it clearly improves outcomes for learners. We don’t use it as a shortcut or a replacement for people, but as a tool to enhance learning experiences and efficacy. Duolingo has been named to: Fast Company’s Most Innovative Education Company (2026, 2022), Apple Design Award (2023), TIME100 Most Influential Companies (2023), Fast Company Best Workplaces for Innovators (2022), among others.
2025
Investor
May 2025
Hims & Hers Health, Inc. (better known as Hims & Hers) is a multi-specialty telehealth platform building a virtual front door to the healthcare system. We connect consumers to licensed healthcare professionals, enabling people to access high-quality medical care—from wherever is most convenient—for numerous conditions related to sexual health, hair care, mental health, skincare, primary care, and more. With products and services available across all 50 states and Washington, D.C., Hims & Hers is on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. We normalize health & wellness challenges—and innovate on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so we provide access to personalized care designed for results. At our core, our mission is deeply personal—because we too are customers. In January 2021, the company was listed on the NYSE and is traded under the ticker symbol “HIMS”. To learn more about our brand and offerings, you can visit hims.com and forhers.com.
Investor
Jan 2025
Trade. Invest. Earn.  rbnhd.co/social_media_disclosures
Investor
Jan 2025
Strategy (Nasdaq: MSTR) is the first and largest Bitcoin treasury company, and the leading provider of universal semantic layer and AI+BI software for enterprises. Formerly known as MicroStrategy, we rebranded to Strategy in 2025 to reflect our bold vision: empowering the world’s most data-driven organizations to lead with intelligence. Today, Strategy operates at the intersection of analytics, AI, semantic layer, and Bitcoin. Our software business is anchored by two flagship products: • Strategy Mosaic – the industry’s most mature universal semantic layer, enabling enterprises to unify data across silos, define business logic once, and power governed insights in any BI tool, productivity app, or AI agent. Mosaic is semantic-first, open by design, and built to make your data stack interoperable, AI-ready, and cost-efficient. • Strategy One – our AI-powered analytics platform for decision intelligence, trusted by business teams to create, share, and act on insights at enterprise scale. From dashboards to hypercards to embedded analytics, Strategy One drives real-time visibility and action. Our 35+ year track record speaks for itself: we’re trusted by thousands of organizations across every industry to deliver scalable analytics with unparalleled governance, security, and performance. And with over $70B in Bitcoin holdings, we continue to explore the future of finance by combining software innovation with a long-term Bitcoin strategy. We’re not just a software company. We’re a strategy for data, for AI+BI, for the future. Learn more about our software products at https://www.strategy.com/software. For investor information, visit strategy.com.
Investment activity
2025–2026 · 4 investments
2025320261
Recent (last 2 years)Earlier